Results 51 to 60 of about 10,639 (243)
This study identifies C4 as a lead inhibitor of the Lpt system. Notably, C4 potentiates colistin activity by disrupting LPS transport and remodeling phospholipid homeostasis, revealing a functional interplay between the Lpt and Mla systems. These findings establish a mechanistic link between Lpt inhibition and membrane lipid remodeling, positioning Lpt–
Jianya Luo +6 more
wiley +1 more source
Resistance to polymyxins: genetic bases, epidemiology, and detection issues [PDF]
Polymyxins are old designed antibiotics that have recently regained significant interest as a consequence of the increasing prevalence of infections due to multidrug-resistant Gram-negative bacteria.
Endimiani, Andrea
core
Potential toxicity of polymyxins in human lung epithelial cells [PDF]
Inhaled polymyxins are of considerable utility in achieving optimal exposure in the respiratory tract for the treatment of lung infections caused by multidrug-resistant Gram-negative pathogens.
Lin, Yu-Wei +19 more
core +1 more source
Colistin therapy is associated with the development of nephrotoxicity. We examined the incidence and risk factors of nephrotoxicity associated with colistin dosing.
Reem Almutairy +6 more
doaj +1 more source
Polymyxin E (colistin) is a medically important active substance both in human and veterinary medicine. Colistin has been used in veterinary medicine since the 1950s.
Wiebke Jansen +5 more
doaj +1 more source
This study firstly isolated a tuna‐derived gut probiotic Acinetobacter seifertii YFT067. Dietary administration of YFT067 played significant roles in promoting growth performance, SCFAs production, lipid absorption, and metabolism of the host, indicating YFT067 as a promising probiotic candidate for enhancing tuna aquaculture productivity through ...
Ying Zou +4 more
wiley +1 more source
Polymyxins: To Combine or Not to Combine?
Polymyxins have been a mainstay for the treatment of extensively drug resistant (XDR) Gram-negative bacteria for the past two decades. Many questions regarding the clinical use of polymyxins have been answered, but whether the administration of ...
Federico Perez +5 more
core +1 more source
Background/Objectives: The feasibility of repurposing selective serotonin reuptake inhibitors as adjunctive antibacterial agents is an area of current investigation.
Samar A. Ahmed +3 more
doaj +1 more source
Polymyxins resistance: old antimicrobials, last therapeutic options
Polymyxins are polypeptide antimicrobials that act in the cell membranes and promote decrease of the cell wall integrity. These antimicrobials are used in the clinical practice for treatment of the multi-drug resistant Gram negative bacilli infections ...
Raquel Girardello, Ana Cristina Gales
doaj +1 more source
Here, we characterized in public health organizations prevalence of carbapenemase-producing Klebsiella pneumoniae, sensitivity to antimicrobial agents (AMAs), combined antimicrobial agents, and decontaminants.
D. V. Tapalski +2 more
doaj +1 more source

